Atea Pharmaceuticals Inc (AVIR)
3.70
-0.03
(-0.80%)
USD |
NASDAQ |
Apr 24, 16:00
3.705
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Shareholders Equity (Quarterly): 555.19M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 555.19M |
| September 30, 2023 | 581.73M |
| June 30, 2023 | 602.35M |
| March 31, 2023 | 618.18M |
| December 31, 2022 | 640.57M |
| September 30, 2022 | 663.19M |
| June 30, 2022 | 660.46M |
| March 31, 2022 | 679.88M |
| Date | Value |
|---|---|
| December 31, 2021 | 710.08M |
| September 30, 2021 | 581.45M |
| June 30, 2021 | 597.86M |
| March 31, 2021 | 586.26M |
| December 31, 2020 | 547.80M |
| September 30, 2020 | -76.51M |
| June 30, 2020 | 112.62M |
| December 31, 2019 | -49.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-76.51M
Minimum
Sep 2020
710.08M
Maximum
Dec 2021
500.72M
Average
592.06M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Protalix BioTherapeutics Inc | 33.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 594.97M |
| Total Liabilities (Quarterly) | 39.78M |